Suppr超能文献

HiViPore:一种在微流控中实现一步法细胞机械穿孔的高可行性内流压缩技术,可实现纳米- 宏观货物的自由递送。

HiViPore: a highly viable in-flow compression for a one-step cell mechanoporation in microfluidics to induce a free delivery of nano- macro-cargoes.

机构信息

Interdisciplinary Research Centre on Biomaterials (CRIB), Dipartimento di Ingegneria Chimica, dei Materiali e della Produzione Industriale, University of Naples "Federico II", Naples, 80125, Italy.

Center for Advanced Biomaterials for Healthcare@CRIB, Istituto Italiano di Tecnologia, Naples, 80125, Italy.

出版信息

J Nanobiotechnology. 2024 Jul 27;22(1):441. doi: 10.1186/s12951-024-02730-y.

Abstract

BACKGROUND

Among mechanoporation techniques for intracellular delivery, microfluidic approaches succeed in high delivery efficiency and throughput. However, especially the entry of large cargoes (e.g. DNA origami, mRNAs, organic/inorganic nanoparticles) is currently impaired since it requires large cell membrane pores with the need to apply multi-step processes and high forces, dramatically reducing cell viability.

RESULTS

Here, HiViPore presents as a microfluidic viscoelastic contactless compression for one-step cell mechanoporation to produce large pores while preserving high cell viability. Inducing an increase of curvature at the equatorial region of cells, formation of a pore with a size of ~ 1 μm is obtained. The poration is coupled to an increase of membrane tension, measured as a raised fluorescence lifetime of 12% of a planarizable push-pull fluorescent probe (Flipper-TR) labelling the cell plasma membrane. Importantly, the local disruptions of cell membrane are transient and non-invasive, with a complete recovery of cell integrity and functions in ~ 10 min. As result, HiViPore guarantees cell viability as high as ~ 90%. In such conditions, an endocytic-free diffusion of large nanoparticles is obtained with typical size up to 500 nm and with a delivery efficiency up to 12 times higher than not-treated cells.

CONCLUSIONS

The proposed one-step contactless mechanoporation results in an efficient and safe approach for advancing intracellular delivery strategies. In detail, HiViPore solves the issues of low cell viability when multiple steps of poration are required to obtain large pores across the cell plasma membrane. Moreover, the compression uses a versatile, low-cost, biocompatible viscoelastic fluid, thus also optimizing the operational costs. With HiViPore, we aim to propose an easy-to-use microfluidic device to a wide range of users, involved in biomedical research, imaging techniques and nanotechnology for intracellular delivery applications in cell engineering.

摘要

背景

在用于细胞内递送的机械穿孔技术中,微流控方法在高递送效率和高通量方面取得了成功。然而,特别是对于大的货物(例如 DNA 折纸、mRNA、有机/无机纳米颗粒)的进入目前受到限制,因为它需要具有需要应用多步过程和高力的大细胞膜孔,这极大地降低了细胞活力。

结果

这里,HiViPore 提出了一种用于一步细胞机械穿孔的微流控粘弹性无接触压缩方法,以产生大孔,同时保持高细胞活力。在赤道区域诱导细胞曲率增加,形成尺寸约为1μm的孔。孔化与膜张力的增加耦合,通过平面化推拉荧光探针(Flipper-TR)标记细胞膜的荧光寿命提高 12%来测量。重要的是,细胞膜的局部破坏是短暂的和非侵入性的,细胞完整性和功能在10 分钟内完全恢复。结果,HiViPore 保证了高达~90%的细胞活力。在这种情况下,可以实现大纳米颗粒的无内吞扩散,典型尺寸高达 500nm,并且与未经处理的细胞相比,递送效率提高了 12 倍。

结论

提出的一步无接触机械穿孔方法为推进细胞内递送策略提供了一种高效、安全的方法。具体来说,HiViPore 解决了需要多次穿孔才能获得穿过细胞膜的大孔时细胞活力低的问题。此外,压缩使用了一种多功能、低成本、生物相容性的粘弹性流体,从而还优化了运营成本。使用 HiViPore,我们旨在向涉及生物医学研究、成像技术和纳米技术的广泛用户提出一种易于使用的微流控设备,用于细胞工程中的细胞内递送应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c2/11282774/572be8995a27/12951_2024_2730_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验